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Abstract
Background: Protein kinase C (PKC) is expressed in many tissues and organs including the urinary bladder,
however, its role in bladder physiology and pathophysiology is still evolving. The aim of this review was to evaluate
available evidence on the involvement of PKC in regulation of detrusor contractility, muscle tone of the bladder
wall, spontaneous contractile activity and bladder function under physiological and pathophysiological conditions.
Methods: This is a non-systematic review of the published literature which summarizes the available animal and
human data on the role of PKC signaling in the urinary bladder under different physiological and
pathophysiological conditions. A wide PubMed search was performed including the combination of the following
keywords: “urinary bladder”, “PKC”, “detrusor contractility”, “bladder smooth muscle”, “detrusor relaxation”, “peak
force”, “detrusor underactivity”, “partial bladder outlet obstruction”, “voltage-gated channels”, “bladder nerves”, “PKC
inhibitors”, “PKC activators”. Retrieved articles were individually screened for the relevance to the topic of this review
with 91 citations being selected and included in the data analysis.
Discussion: Urinary bladder function includes the ability to store urine at low intravesical pressure followed by a
subsequent release of bladder contents due to a rapid phasic contraction that is maintained long enough to
ensure complete emptying. This review summarizes the current concepts regarding the potential contribution of
PKC to contractility, physiological voiding, and related signaling mechanisms involved in the control of both the
storage and emptying phases of the micturition cycle, and in dysfunctional voiding. Previous studies linked PKC
activation exclusively with an increase in generation of the peak force of smooth muscle contraction, and
maximum force generation in the lower urinary tract. More recent data suggests that PKC presents a broader range
of effects on urinary bladder function including regulation of storage, emptying, excitability of the detrusor, and
bladder innervation.
Summary: In this review, we evaluated the mechanisms of peripheral and local regulation of PKC signaling in the
urinary bladder, and their impact on different phases of the micturition cycle under physiological and
pathophysiological conditions.
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Background
Physiological contractions of the detrusor smooth
muscle (DSM) involve the ability to generate and
maintain contractile force during the emptying phase
of the micturition cycle [1–13]. Initial animal studies
suggested that PKC plays a minimal role in DSM
contractility [14–19]. This conclusion was based on the
failure of PKC to make a significant contribution to
maximal force generation in response to muscarinic
receptor agonists [14, 16, 18]. Subsequent investigations
provided evidence that PKC likely has dual effects on
bladder function regulating both contractility and
relaxation of the detrusor [3, 7, 8, 20, 21]. For instance,
it was determined that low levels of PKC stimulation
could inhibit spontaneous contractions and lower basal
resting tone of DSM in vitro, thereby, likely contribut-
ing to bladder storage [8], while high levels of PKC
activity contributed to an increase and maintenance of
total DSM force (integral force) required for bladder
emptying [22].
Stimulation of muscarinic receptors triggers activation
of phospholipase C (PLC)/PKC downstream signaling
associated with smooth muscle contractility via G-
protein-coupled receptors [15, 16, 23, 24]. Animal studies
confirmed that the same pathway is present in the urinary
bladder [15], and that PKC is involved in a variety of cellu-
lar events that regulate DSM contractility. Among these are
the effects on the smooth muscle itself [3, 7, 8, 17, 25–30],
expression and function of ion channels [8, 26, 31–33], and
intrinsic bladder nerves assessed by in vitro contractility
studies on isolated DSM strips during electric field stimula-
tion (EFS) [22, 34, 35]. In this review, we summarized
current data on the involvement of PKC signaling in
modulation of bladder function with focus on the
contractile force of DSM, relaxation of the muscle
during filling phase, as well as the ability of the
detrusor to develop and maintain muscle tone
throughout the micturition cycle under physiological
and pathophysiological conditions.
Methods
This is a non-systematic review of the published literature
which summarizes the available animal and human data
on the role of PKC signaling in the urinary bladder under
different physiological and pathophysiological conditions.
A wide PubMed search was performed including the com-
bination of the following keywords: “urinary bladder”,
“PKC”, “detrusor contractility”, “bladder smooth muscle”,
“detrusor relaxation”, “peak force”, “detrusor underactiv-
ity”, “partial bladder outlet obstruction”, “voltage-gated
channels”, “bladder nerves”, “PKC inhibitors”, “PKC
activators”. Retrieved articles were individually screened
for the relevance to the topic of this review with 91
citations being selected and included in the analysis.
Table 1 summarizes the effects of a variety of PKC in-
hibitors, activators, and cholinergic agonists on PKC sig-
naling and contractility of DSM.
Discussion
The aim of this review was to evaluate the available
evidence on the involvement of PKC in regulation of
detrusor contractility, muscle tone of the bladder wall,
spontaneous contractile activity and bladder function
under physiological and pathophysiological conditions.
Modulation of DSM excitability and ion channel activity
by PKC
Bladder smooth muscle cells express a variety of ion
channels controlling cell excitability. Voltage-gated
calcium channels (VGCC), large- (BK), and small- (SK)
conductance Ca2+-activated potassium channels, and
ATP-sensitive potassium channels (KATP) are the main
channels involved in the control of detrusor excitability
and excitation-contraction coupling [4, 15, 26, 32, 36].
Voltage gated calcium channels
Several types of VGCC are expressed in the detrusor
[15] with L-type VGCC being the main ion channel
responsible for the onset of action potentials in DSM
cell, as well as for the contractile response of the
detrusor to muscarinic receptor stimulation [37–42].
VGCC have also been shown to mediate spontaneous
contractions in DSM cells [4]. Recent studies determined
that one of the PKC activators, phorbol-12,13-dibutyrate
(PDBu), inhibited voltage-dependent spontaneous contrac-
tions in isolated DSM strips from rabbit and rat bladders at
low concentrations [8, 22]. Additionally, PKC activation by
PDBu inhibited receptor-induced phasic activity in the
bladders of newborn mice but not in adult bladders [29].
Inhibition of DSM spontaneous contractility by PKC
activator, PDBu, was also observed in isolated muscle
strips of the human DSM (unpublished observations from
our laboratory) and rat DSM [22]. Utilizing whole-cell
patch clamp technique, Kajioka et al. (2002) demonstrated
an increase in the amplitude and current density of L-type
Ca2+ channels upon depolarization in pig and human
bladders [43]. Interestingly, in the same study, carbachol
significantly diminished the amplitude of VGCC current
which was sensitive to nifedipine. The mechanisms of the
opposing actions of carbachol on VGCC are not entirely
clear. It is well established that initial phasic contraction
of DSM in response to carbachol stimulation is associated
with membrane depolarization and opening of VGCC
[15]. However, this initial massive increase in intracellular
calcium is followed by subsequent closing of VGCC and a
decrease in intracellular Ca2+ due to its storage in the
intracellular stores [44]. These subsequent changes are
associated with a quiescent state of the muscle after initial
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phasic contraction, and, likely, underlie the absence of
spontaneous contractile activity during relaxation phase
after muscarinic stimulation (Fig. 1). This action may
be mediated by carbachol-induced activation of PKC
[24] at low or resting calcium concentration, since PKC
stimulation by PDBu was reported to activate BK chan-
nels resulting in inhibition of spontaneous contractions
[8, 22]. Interestingly, pre-incubation of the DSM strips
in vitro with the PKC inhibitor, Bim-1, before carbachol
stimulation preserved spontaneous contractility during
relaxation phase (Fig. 1).
Effects of PKC activation on BK channels
The storage phase of the micturition cycle requires a
quiescent smooth muscle that can accommodate increasing
volumes at low intravesical pressure. Potassium channels
contribute to this process by helping maintain the resting
membrane potential via regulation of both the intracellular
calcium concentration, and calcium entry into the cell from
extracellular sources [32, 36, 45]. Several types of potassium
channels are expressed in DSM, and are known to be
involved in this regulation. Among them, BK and KATP
channels were shown to be regulated by PKC. PKC was
Table 1 Effects of PKC signaling on bladder function
PKC Drugs Tissue Methods Physiological
condition
Species Effect on bladder function Reference






PDBu Muscle strips In vitro Normal Rabbit Increased contractility [8, 25, 28]
(100nM-1 μM)




PDBu Bladder In vivo
(cystometry)




PDBu Muscle strip In vitro Normal Rabbit Activation of ROCK, Increased
DSM tone
[28]
PDBu Muscle strips In vitro, EFS Normal Rat Increased peak force and area;
increased release of acetylcholine.
[30]
PDBu Bladder myocytes In vitro Normal Mice Increased Cav1.2 current [33]
PDBu α-toxin muscle strips In vitro Normal Guinea pig Increased Ca2+ sensitivity [80]
PDBu Muscle strips In vitro Obese Mice Increased contractility [26]
(0.001–3 μM) PBOO [60]
PDBu Muscle strips In vitro PBOO Rabbit Decreased contraction and
PKC activity
[25, 27]
PMA DSM cells & Muscle
strips





Bim-1 Muscle strips In vitro Normal Rabbit Increased spontaneous contractions;
decreased force maintenance;




(PKC inhibitor) Bladder In vivo Normal Rat
Ro318220 Muscle strips In vitro Normal Rat Inhibition of force maintenance; [22]
(PKC inhibitor) Bladder In vivo Normal Rat Increased non-voiding contractions;
decreased void volume
GF109203X Muscle strips In vitro Normal Guinea pig; rat Inhibition of Ca2+ sensitization [17]
(PKC inhibitor)
Carbachol DSM cells In vitro,
Patch-clamp
recordings
Unknown Human Inhibition of BK channels [76]
Carbachol DSM In vitro Unknown Human Increased Ca++ sensitivity of
contractile filaments
[68]
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shown to be involved in the regulation of BK channels
expressed in DSM tissue of rabbit [8] and guinea pig [31]
bladders. Hypolite et al. (2013) reported that low levels of
PKC stimulation by the PKC activator, PDBu, inhibited
spontaneous myogenic contractions, and reduced basal
DSM tone in rabbit DSM, which was dependent on activa-
tion of BK channels [8]. Additionally, PDBu was unable to
inhibit spontaneous contractions in the presence of the
BK channel blocker, iberiotoxin, suggesting that the mech-
anism of PDBu-induced inhibition of spontaneous con-
tractions was via activation of BK channels. Utilizing
whole-cell patch clamp recordings in guinea pig DSM
cells, Hristov et al. (2014) confirmed that PKC does regu-
late BK channel activity, however, these authors reported
that PKC stimulation with PMA increased muscle force
along with amplitude of spontaneous contractions [31].
The variability in the responses to PKC stimulation re-
ported by the abovementioned studies could be attributed
to different species (guinea pigs vs rabbits), or the use of
distinct PKC activators (PDBu versus PMA), as well as
slightly different methodological approaches.
Modulation of KATP channels by PKC
Similar to BK channels, KATP channels also participate in
the control of detrusor excitability across a broad spectrum
of mammalian species including guinea pigs [46, 47],
humans [48], and rats [49]. Activation of these channels
induces DSM relaxation in response to KATP channel
openers pinacidil [50], and cromakalim [51]. Activation of
M3 receptors can induce inhibition of these channels in
smooth muscle cells via PKC signaling pathways [52].
Stimulation of muscarinic receptors by carbachol was
shown to inhibit KATP currents by 60.7 %, while acti-
vators of PKC inhibited KATP channels by 74 % [52].
Additionally, PKC blockers used before stimulation
with muscarinic receptor agonists, significantly reduced
carbachol-induced inhibition of KATP currents confirming
that muscarinic-dependent inhibition of KATP currents is
mediated via PKC pathways [52]. This speculation is
consistent with in vitro studies showing that the PKC
inhibitor, Bim-1, reduced both intrinsic basal tone, and
maintained force [8], while awake cystometry performed in
rats revealed that inhibition of PKC resulted in increased
frequency of urination, and decreased void volume [22].
Schematic presentation of the ion channels involved in
regulation of BSM excitability and contractility as well as
downstream signaling including PKC pathways is depicted
in Fig. 2.
The link between muscarinic receptors and PKC signaling
in the control of detrusor contractility
Muscarinic receptor type 3 (M3) signaling via Gq/11 G-
protein-coupled receptors includes activation of PLC/PKC
as determined for several types of smooth muscle [23]
including the DSM of the bladder [16, 53–55]. Initial exper-
iments in the urinary bladder established that inhibition of
PLC/PKC pathway by a number of specific inhibitors had
no significant effect on maximal contractility of rat bladder
Fig. 1 Effects of carbachol (CCh) on the contractile force and spontaneous contractions in DSM in vitro. Isolated muscle strips from rabbit
bladders were mounted in organ baths with Tyrode’s buffer (equilibrated with 95%O2/5%CO2) and allowed to develop spontaneous contractions.
The muscle strip shown in a was treated with 20 μM of carbachol while the muscle strip in b was first pre-incubated with Bim-1 (28 nM), a PKC
inhibitor, for 45 min prior to adding carbachol. Treatment with carbachol increased peak muscle force and reduced the amplitude of spontaneous
contraction (SCA) by 96 ± 14 %, (n = 4, p < 0.05 in a), however, carbachol had no effect on spontaneous contraction amplitude (SCA) after PKC
inhibition with Bim-1 (b). c Normalized amplitude of the peak force of the contractile response to CCh. Maximal amplitude was taken as 100 %.
Light bars show the effects of carbachol on peak force and SCA without Bim-1. Dark bars show the effect of carbachol on peak force and SCA
with Bim-1 application
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muscle strips in response to carbachol stimulation leading
to the conclusion that PLC/PKC-dependent signaling via
M3 receptors does not significantly contribute to DSM
contractility [16]. This data was further buttressed by the
studies showing that direct inhibition of PKC had no
significant effect on the peak contractile force in response
to both carbachol and EFS stimulation [8, 14].
An exception to the above findings was the observation
that one of the PKC inhibitors, Bim-1, did reduce maximal
force in response to carbachol upon application of a
higher concentration of the inhibitor [24]. Another PKC
inhibitor, GF 109203X (1 μM), was also reported to reduce
peak force in control bladders by 29 % [56]. Subsequent
studies clarified that inhibition of PKC with Bim-1, at lower
concentrations, did not significantly affect electric field
stimulation (EFS)-induced maximal amplitude of DSM
contractions, however, significantly reduced the integral, or
total force [8, 22]. The integral (total) force is calculated as
the area under the curve of a single recorded contraction,
and represents the ability of DSM to maintain muscle force
required for physiological bladder emptying [8]. The effects
of Bim-1 observed in vitro were further confirmed in vivo
by cystometric recordings in unanesthetized rats [22].
During urodynamic recordings (cystometry), the urinary
bladder was slowly infused with a solution containing Bim-
1, causing the voided urine volumes to decline progressively
in comparison with infusion of saline in the control group.
These in vivo results supported the importance of PKC
for muscle force maintenance associated with bladder
emptying.
Additional studies confirmed the involvement of PKC
in the maintenance of muscle force at the molecular and
biochemical level [24]. Stimulation of muscarinic recep-
tors in the smooth muscle results in inhibition of myosin
light chain (MLC) phosphatase activity, an increase in
MLC phosphorylation and, therefore, contractile force.
One of the underlying pathways for inhibition of MLC
phosphatase activity is protein kinase C (PKC)-catalyzed
phosphorylation of CPI-17 protein [57, 58]. Wang and
co-authors evaluated phosphorylation of protein com-
plex Thr(38)-CPI-17, the downstream target of PKC
signaling, and established that PKC activation increased
Thr(38)-CPI-17 phosphorylation throughout the phasic
and tonic portions of carbachol stimulation confirming
that PKC is involved in maintaining the contractile
force in the detrusor [24].
Limited contribution of the PLC/PKC pathway to the
peak amplitude of the contractile response in DSM seems
to be physiologically justified as the maximal contractile
force of smooth muscle is predominantly controlled by
Fig. 2 Schematic presentation of the PKC signaling pathways involved in the regulation of urinary bladder function. Abbreviations are spelled out
in the text of the manuscript. (+) Activation of the pathways, (−) means Inhibition, (P) is Phosphorylation. Broken arrows indicate potential
pathways for PKC-induced inhibition of DSM tone via activation of BK channels
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calcium/calmodulin-dependent activation of myosin light
chain kinase (MLCK) followed by subsequent phosphoryl-
ation of the myosin light chain (MLC) [59]. Since stimula-
tion of DSM by muscarinic receptor agonists leads to a
rapid rise in intracellular calcium followed by an
equally rapid decline of the calcium to almost basal
levels [44], it is highly likely that PKC-induced calcium
sensitization via Gq11 receptors [3] plays a major role
in the maintenance phase of the contraction that is
critical for bladder emptying. This mechanism may
partly explain why inhibition of PKC significantly reduces
DSM force maintenance, and bladder emptying, without
significantly affecting peak force generation [14, 22].
Role of PKC in regulation of spontaneous contractions in
the urinary bladder
Protein kinase C is also involved in other aspects of
DSM contractility, including the inhibition of basal DSM
tone, and spontaneous myogenic contractions [8, 22].
For instance, PDBu, a PKC activator, inhibits spontan-
eous contractions, and basal myogenic tone at low levels
of application (1–50 nM) whereas high concentrations
of the drug increase the sensitivity to EFS stimulation in
vitro, and also trigger micturition contractions in vivo
confirming a dual, concentration-dependent activation
profile of PKC effects in DSM [22]. The ability of PKC
to modulate basal DSM tone, and inhibit spontaneous
contractions at low levels of stimulation may have
physiological implications for bladder storage function,
while its contribution to the maintenance of DSM force
and nerve-mediated contractions may be important for
bladder emptying.
Spontaneous myogenic contractions of DSM have been
recorded in vivo and in vitro in several species including
rabbit [8, 11], rat [60], guinea pig [31], pig [40], and
humans [61]. The mechanism of these contractions
involves calcium entry into the smooth muscle cells via
VGCC [40, 43, 62, 63] to trigger action potential gener-
ation, while the repolarization phase is thought to be
mediated mainly by opening of calcium-activated potas-
sium channels and exit of potassium ions from the
smooth muscle cells leading to muscle relaxation [64].
Early reports suggested that spontaneous large-amplitude
contractions recorded in vitro in isolated DSM strips were
likely an artifact with no significant functional role [11].
Subsequent studies suggested that these contractions
participate in the maintenance of an intrinsic DSM tone
by helping the smooth muscle adjust its length and
shape in response to bladder filling [4]. They have also
been reported to be associated with peripheral sensory
processing that informs the need to void as the bladder
approaches capacity [6].
The inhibitory effect of the PKC activator, PDBu, on
spontaneous contractions was linked to activation of BK
channels, subsequent hyperpolarization of the membrane,
and restriction of calcium entry via VGCC [8, 65]. Freshly
isolated DSM strips from the rabbit bladder exhibit high
amplitude spontaneous contractions which decline over
several hours, however, the amplitude of contractions
remains at a high level in the presence of PKC inhibitor
Bim-1 [8]. This observation suggests that endogenous PKC
signaling likely maintains the amplitude of spontaneous
contractions at a low, physiological level under normal
physiological conditions. This assumption is supported by
the fact that commercially available PKC activator, PDBu, at
low levels of stimulation (1–50 nM), accelerated the decline
in amplitude of spontaneous contractions over time in vitro
[8]. PDBu was also reported to inhibit carbachol-induced
phasic contractions in neonatal bladders associated with
the effects on T-type channels [29], and was also observed
to inhibit spontaneous contractions in rat DSM [22].
Effects of calcium on PKC activity
Protein kinase C conveys both calcium-dependent [66–68],
and calcium-independent [3, 68, 69] effects on DSM
contractility in vitro mediated via inhibition of MLCP. It is
still unknown if these separate effects are mediated by
different PKC isoforms. However, the ability of PKC to
mediate both of these actions in DSM may be well suited
to urinary bladder storage and emptying function. The
storage phase requires the maintenance of basal intrinsic
DSM tone at low calcium concentrations which can be
mediated, in part, by calcium-independent contractile
effects of PKC involved in an increase in tone during the
storage phase. This process may be aided by the stretch of
the bladder wall associated with an up-regulation of the
proteins involved in calcium sensitization [70] and
contributing to the basal tone during the early phase of
the micturition cycle. However, as the bladder continues
to expand, it is likely that enhanced stretch-induced
calcium release [71], and calcium-dependent PKC activity
increase wall tension further as the bladder approaches
capacity. This dual, calcium-independent and dependent,
flexibility of PKC may be vital in helping ensure that wall
tension rises in a controlled fashion so as to prevent
steep increases in bladder pressure during the storage
phase of the micturition cycle. PKC-dependent effects
have been observed in DSM in response to EFS, which
activates the intramural nerves, suggesting that PKC-
dependent regulation of neuronal function in DSM is
also a distinct possibility [65, 72–74].
PKC signaling in the human bladder
In comparison to extensive animal data, very little
information is available regarding the effects of PKC
on human bladder contractility and relaxation. Early
studies using human tissues suggested that PKC did not
significantly contribute to human bladder contractions
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[14]. However, only the peak amplitude of contraction
(maximum force) was evaluated in the presence of various
PKC inhibitors, and no difference was found in peak force
generation in comparison to the absence of inhibitors.
Since bladder emptying requires both, the generation
of peak force and the ability to maintain force, it is
possible that PKC could play a more significant role in
force maintenance in the human DSM in addition to
force generation.
A recent study [75] provided evidence that carbachol, a
muscarinic receptor agonist, could indirectly inhibit large
conductance Ca2+-activated potassium (BK) channels in
human DSM cells leading to increased excitability [76].
This is an interesting finding as the ongoing studies in our
laboratory using human DSM indicate that carbachol can
induce a significant increase in phasic contractions in some
human DSM isolated strips, but not in all of them (unpub-
lished data). It is possible that PKC could be an important
secondary messenger between muscarinic receptors and
BK channels in the human detrusor. Therefore, further
studies are warranted to comprehensively characterize the
role of PKC in the regulation of cholinergic activity in the
human DSM under normal and pathologic conditions.
Regulation of bladder function by PKC under
pathophysiological conditions
The role of PKC in bladder pathophysiology is largely
related to DSM contractile dysfunction and dysfunctional
voiding associated with partial bladder outlet obstruction
(PBOO), and detrusor overactivity (DO). Initial studies,
using a PBOO model in rabbits, reported that PKC
signaling under pathophysiological conditions was
uncoupled from its downstream targets and produced
little or no force in response to PKC activator, PDBu
[27]. Chang et al. [25] also determined that decreased
force generation in decompensated PBOO bladders in
response to PKC activator, PDBu, was associated with
reduced expression of PKC and increased frequency of
urination in the obstructed bladders. It should be noted,
however, that a broad range of contractile and metabolic
dysfunctions were linked to decompensated bladder func-
tion in PBOO models [77, 78]. Further studies confirmed
a deficit in the PKC pathway in guinea pig DSM after
PBOO [79]. Partial bladder outlet obstruction causes two
phenotypes of bladder dysfunction referred to as compen-
sated and decompensated bladders [25, 77]. Compensated
bladders are characterized mainly by increased smooth
muscle hypertrophy, however, residual urine and
frequency of micturition have been reported in com-
pensated bladders associated with PKC dysfunction
[25, 80, 81]. Decompensated bladders develop an
increase in extracellular matrix including collagen and
connective tissue resulting in a loss of bladder compliance,
decreased contractility, and a substantial loss of bladder
emptying function [25, 77, 78, 80–83]. Changes in PKC
expression and activity in a PBOO model seem to be
dependent on the species and degree of obstruction. Thus,
in the rabbit model of PBOO, decompensated bladders
revealed a reduction in PKC expression, activity and force
generation associated with reduced bladder emptying and
frequency of urination, while compensated bladders
exhibited increased PKC expression [25]. However, in the
rat bladders with PBOO, PKC expression was reduced
in both compensated, and decompensated bladders
[81]. Additionally, recent in vivo studies established
that inhibition of PKC during cystometric recordings
in awake rats induced bladder decompensation char-
acterized by an increase in non-voiding contractions
(DO), and a significant decrease in void volume [22].
Increased PKC-mediated frequency of urination along
with DO have also been reported in the absence of PBOO.
In a model of obesity associated with insulin resistance,
PKC expression was significantly higher in the bladders of
obese mice [26] which showed increased contractility to
PDBu, increased frequency, and non-voiding contractions.
The changes in the voiding cycle were reversed by metfor-
min treatment which restored high PKC expression in the
urinary bladders. High levels of PKC stimulation in rat
bladders [22], and high level of expression in compensated
rabbit bladders [25] were associated with enhanced nerve-
mediated contractions, and frequency of urination,
respectively. Thus, a high level of PKC activity and expres-
sion may lower the threshold for activation of intramural
nerves leading to neurogenic frequency of urination in
both diabetic, and compensated bladders. It was estab-
lished that the protein adiponectin, expressed in adipose
tissue, contributed to the increased expression of calcium-
dependent PKC-α and enhanced contractile force of DSM
in adiponectin-sense transgenic mice [67]. Additionally,
carbachol-induced phosphorylation of PKC-α was also
elevated in these animals in comparison with WT mice
suggesting that adiponectin increases calcium dependency
of DSM contractions mediated by PKC-α expression.
It was previously shown that reduced expression of PKC
in decompensated rabbit bladders was associated with
increased frequency, decreased void, and consequently
large residual volumes [25]. Additional cystometric studies
in awake rats also revealed that pharmacological inhibition
of PKC by Bim-1, and Ro318220 induced an increase in
non-voiding contractions, frequency, and decreased void
volume [22]. Interestingly, both inhibitors of PKC signifi-
cantly reduced the ability to maintain muscle force of
DSM but did not affect the sensitivity of force generation
in response to EFS-mediated nerve stimulation. These
data indicate that resting and low levels of PKC activity do
not have a significant effect on nerve-mediated contractions
in DSM. The ability to maintain DSM force is largely a
function of the smooth muscle, and involves calcium
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sensitization mechanisms mediated by PKC, and Rho-kinase
in a calcium-independent manner [3, 8, 24, 68]. Therefore,
the frequency of micturition induced by reduced expression
of PKC in decompensated rabbit bladders, and pharmaco-
logic inhibition during cystometry in rat bladders are largely
myogenic. The inability to maintain muscle force due to sig-
nificantly low levels of PKC activity results in reduced bladder
emptying, increased residual volumes, and an overall shorten-
ing of the micturition cycle leading to voiding frequency [22].
Partial bladder outlet obstruction, well known for its
prevalence in aging males and often secondary to benign
prostatic hyperplasia, has also been shown to alter struc-
tural proteins within the bladder wall leading to reduced
compliance, DO, and frequency of urination. Among the
structural proteins altered in PBOO are smooth muscle
myosin (SMM) [84] collagen [85], caldesmon [80] and con-
nective tissue [86]. A change in the ratio and organization
of smooth muscle to non-smooth muscle elements is gen-
erally believed to lead to stiffening of the bladder wall, and
a reduction in compliance resulting in a reduced storage
capacity, and frequency of urination [77, 80, 85, 87]. How-
ever, significant changes in structural elements such as con-
nective tissue, and collagen may represent some of more
severe consequences of acute bladder outlet obstruction,
associated with bladder decompensation, and may not
represent some of the more subtle changes in bladder func-
tion that occur due to changes in regulatory proteins and
associated with bladder compensation [3, 25, 88, 89].
Figure 3 highlights the changes which characterize a
milder form of dysfunction in compensated bladders
such as decreased relaxation and increased DSM tone
in response to the PKC activator, PDBu. Low levels of
PKC stimulation which induce inhibition in normal
DSM (panel A1) resulted in increased force in com-
pensated DSM (panel A2). Additionally, moderate to
high levels of PKC stimulation caused a modulated
rise in tension in normal bladder DSM (panel B1), but
a linear increase in the compensated DSM (panel B2).
A failure to relax sufficiently and a linear, instead of a
modular, increase in DSM tone are the contributing
factors to a higher bladder pressure and bladder
dysfunction observed in compensated bladders in
comparison with normal and sham-operated controls.
Study limitations
We acknowledge that our study has several limitations.
First, we were not able to find any direct data on the
role of PKC signaling in detrusor underactivity nor
whether PKC pathways could be pharmacologically
targeted to improve this condition. Second, we could
Fig. 3 Low and high levels of PKC stimulation by PDBu differentially affect DSM tone and spontaneous contractions. a Representative isolated muscle
strips showing the effect of low (20nM) PDBu stimulation on sham (upper trace) and PBOO (lower trace) DSM strips from rabbits. Summary data is
presented in c. b Representative isolated muscle strips showing the effect of high (100 nM) PDBu stimulation on sham (upper trace) and PBOO (lower
trace). Summary data is presented in d. Low PDBu stimulation caused a significant inhibition of spontaneous contraction amplitude (SCA) of the sham
muscle strips but only a minor effect in PBOO strips, however low PDBu caused a significant increase in basal DSM tone in the PBOO strips. High PDBu
stimulation caused a significant increase in basal DSM tone for both sham and PBOO, however, there was a qualitative difference in the profile of the
contractions. The force increase in the sham bladders displayed a biphasic effect whereas an increase in PBOO muscle strips tended to be more linear.
High PDBu also significantly reduced the amplitude of spontaneous contractions for both sham and PBOO muscle strips
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not find sufficient information on the role of PKC
pathways in sensory and efferent innervation of the
lower urinary tract. This could be especially important
for understanding the role of PKC in other pathological
urologic conditions such as chronic pelvic pain (CPP)
and bladder pain syndrome (BPS) [90, 91]. For example,
a high level of PKC expression and/or activity has been
suggested to play a role in feline interstitial cystitis [73],
a naturally occurring bladder pain and dysfunctional
voiding in cats. It would be of interest to determine
whether or not PKC is overexpressed in these bladders,
since high PKC stimulation was shown to increase
bladder wall tension, and enhance neuronal sensitivity
and contractility [8, 22, 25, 28]. Third, future studies
focused on the role of PKC in the bladder urothelium
are required to clarify the role of epithelial PKC in
micturition.
Conclusions
PKC function in the urinary bladder extends far beyond
its contribution, or the lack thereof, to maximum force
generation in response to agonists, either directly, or in
response to EFS. Data indicate that PKC is involved in
the regulation of normal bladder function, and that PKC
dysfunction is associated with DO, reduced contractility,
and decreased void volume. Relaxation and modulation
of spontaneous myogenic, and NVC via PKC-dependent
activation of BK and KATP channels may also be one of
its primary functions in support of bladder storage. Both
in vitro, and in vivo studies reveal that PKC may be
involved in regulating neuronal activity at the peripheral
level in a concentration-dependent manner that may
function in a complementary way to facilitate voiding.
Finally, the demonstration that PKC dysfunction coexists
with pathological changes such as PBOO, DO and is
associated with reduced contractility and bladder emptying
is further evidence of a significant and important role for
PKC in the regulation of urinary bladder function.
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